Blueprint Medicines
Focus: Blueprint Medicines is a Cambridge-based biotechnology company focused on small-molecule discovery in oncology, women's health, and dermatology. The company is publicly traded and operates as a clinical-stage to commercial-stage biotech with a concentrated revenue base.
Profile data last refreshed 14h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
1
Recent layoff filing — 36 affected
- 6/30/2026 — Fayette, KY · 36 affected · Layoff
Source: state DOL filings via Big Local News
Should You Work at Blueprint Medicines?
AI assessmentBlueprint offers oncology and rare-disease focus with a stable lead product, but recent restructuring and thin hiring suggest a company in transition—suitable for risk-tolerant candidates seeking small-molecule expertise at a shrinking org.
Why Work Here
- AYVAKIT (avapritinib) generates $55M in Part D spending and is at peak lifecycle with exclusivity extending to 2042, providing a stable revenue foundation for R&D investment.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$55M Part DStable
Peak15.7yr
Lead revenue driver representing 83% of company sales; tyrosine kinase inhibitor with long patent runway supporting near-term financial stability.
Help build intelligence for Blueprint Medicines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.